Agenda At A Glance

Plenary Sessions – Next Generation Innovations

Workshop A

Workshop B

Workshop C

Innovating the Future of Cell Therapy with Next Generation Gene Editing

Unlocking the Power of Cord Blood as a Platform for Scalable Manufacturing of Universal Cell Therapy Products

Navigating Through a New Complex Regulatory Landscape to Drive Future Product Development

Workshop D

Workshop E

Workshop F

Moving to the Future: Translating Product Development for an ‘Offthe- Shelf’ World Beyond Oncology

Manufacturing Challenges: Large Scale Complex Editing of Cell Therapy Products

Turning a Universal Dream into a Commercial Reality

Industry Leader’s Fireside Chat

Plenary Sessions - Spotlight on Clinical Validation

Morning Refreshment Break & Speed Networking

Pre-Clinical & Translational

Manufacturing & CMC

Supply/Storage

Advancing Donor-Derived Approaches with Enhanced Screening & Selection

Improving Scalability to Bring the True Promise of Allogeneic Products to Life

Optimizing Cryopreservation to Revolutionize the Cold Supply Chain

Refreshment Break & Networking

Novel Platforms & Cell Types for Greater Safety &
Efficacy of Response

Developing a Safe and Consistent Allogeneic Product for Commercial Readiness

Developing a Robust Supply Chain for Clinical and Commercial
Needs

Refreshment Break & Tech Slam

Advancing Safety with Innovations in Gene Editing

Utilizing Alternative Effector Cells for an Off-the-Shelf Approach

Developing a Robust Supply Chain for Clinical and Commercial
Needs

Plenary Sessions – Next Generation Innovations

Morning Refreshment Break & Poster Session

Pre-Clinical & Translational

Manufacturing & CMC

Supply/Storage

Supercharging Solid Tumor Targeting for Broader Success

Driving Automated Manufacturing & Optimizing Characterization for Successful Commercialisation of Allogenic Therapies

Revolutionizing Data Management & Integration

Refreshment Break

Plenary Sessions – Ushering in the Next Wave of Universal Cell Therapy: Future Directions 

Refreshment Break

Plenary Sessions – Ushering in the Next Wave of Universal Cell Therapy: Future Directions 

Advancing Durability & Persistence

Improving Persistence of Allogeneic Immune Cells for Longer Lasting Therapies

Advancing Durability to Overcome Patient Relapse Following Allogeneic Cell Therapy Treatment

Rethinking Dosing Strategies and Lymphodepletion Regimens to Optimize Persistence & Efficacy

SCHEDULE A CALL to ask your burning questions or for help with registration!